These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8132249)

  • 1. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
    Scherkl R; Hashem A; Frey HH
    Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead intoxication among demolition workers: the effect of lead on the hepatic cytochrome P-450 system in humans.
    Fischbein A; Alvares AP; Anderson KE; Sassa S; Kappas A
    J Toxicol Environ Health; 1977 Oct; 3(3):431-7. PubMed ID: 411946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vasoactive agents in lead-treated rats.
    Skoczyńska A; Stojek E; Górecka H; Wojakowska A
    Int J Occup Med Environ Health; 2003; 16(2):169-77. PubMed ID: 12921385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic oral administration of rhamnogalacturonan-II dimer, a pectic polysaccharide, failed to accelerate body lead detoxification after chronic lead exposure in rats.
    Tahiri M; Tressol JC; Doco T; Rayssiguier Y; Coudray C
    Br J Nutr; 2002 Jan; 87(1):47-54. PubMed ID: 11895313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic levels in blood serum and mandibular bone in rats with and without phenylbutazone administration].
    Teseromati C; Papadopoulos J; Storaiti E; Tralil H
    Hell Stomatol Chron; 1988; 32(1):29-31. PubMed ID: 3153680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug metabolism in normal children, lead-poisoned children, and normal adults.
    Alvares AP; Kapelner S; Sassa S; Kappas A
    Clin Pharmacol Ther; 1975 Feb; 17(2):179-83. PubMed ID: 804369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and effects of repeated administration of phenylbutazone in neonatal calves.
    Semrad SD; McClure JT; Sams RA; Kaminski LM
    Am J Vet Res; 1993 Nov; 54(11):1906-12. PubMed ID: 8291771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the neurotoxic effects of low-level lead exposure in rats.
    Zhu ZW; Yang RL; Dong GJ; Zhao ZY
    J Zhejiang Univ Sci B; 2005 Jul; 6(7):686-92. PubMed ID: 15973774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
    Kietzmann M; Meyer-Lindenberg A; Engelke A; Nolte I
    Dtsch Tierarztl Wochenschr; 1996 Jan; 103(1):14-6. PubMed ID: 8647008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol inhibition of reduced frequency-dependent rundown of calcium currents in acutely dissociated MS/nDB neurons from chronic in vivo lead-exposed adult rats.
    Grover CA; Jasek MC; Frye GD; Griffith WH
    Neurotoxicology; 1997; 18(1):179-90. PubMed ID: 9216000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
    Visser M; Holinka CF; Coelingh Bennink HJ
    Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.